SILVERBACK THERAPEUTICS, INC. CONSULTING SERVICES AGREEMENTConsulting Services Agreement • November 2nd, 2022 • Silverback Therapeutics, Inc. • Pharmaceutical preparations • Washington
Contract Type FiledNovember 2nd, 2022 Company Industry JurisdictionThis Consulting Services Agreement (“Agreement”) is made by and between Silverback Therapeutics, Inc., a Delaware corporation, and its successors or assignees (collectively, “Company”), and the undersigned Laura Shawver, Ph.D. (“Consultant”), and is effective as of September 2, 2022 (the “Effective Date”).
SILVERBACK THERAPEUTICS, INC. CONSULTING SERVICES AGREEMENTConsulting Services Agreement • November 2nd, 2022 • Silverback Therapeutics, Inc. • Pharmaceutical preparations • Washington
Contract Type FiledNovember 2nd, 2022 Company Industry JurisdictionThis Consulting Services Agreement (“Agreement”) is made by and between Silverback Therapeutics, Inc., a Delaware corporation, and its successors or assignees (collectively, “Company”), and Jonathan Piazza (“Consultant”), and is entered into as of September 2, 2022 (the “Effective Date”).
SILVERBACK THERAPEUTICS, INC. CONSULTING SERVICES AGREEMENTConsulting Services Agreement • November 2nd, 2022 • Silverback Therapeutics, Inc. • Pharmaceutical preparations • Washington
Contract Type FiledNovember 2nd, 2022 Company Industry JurisdictionThis Consulting Services Agreement (“Agreement”) is made by and between Silverback Therapeutics, Inc., a Delaware corporation, and its successors or assignees (collectively, “Company”), and Valerie Odegard (“Consultant”), and is entered into as of September 2, 2022 (the “Effective Date”).